TP53 and central nervous system cancer: In this cohort, only the RTK/Ras/PI(3)K, p53 DNA damage repair, WNT signalling, and G-protein pathways were impacted by genetic alterations and not the SHH, NOTCH, and Rb pathways, despite their association with glioma resistance.